An experimental treatment involving stem cells from umbilical cords could significantly reduce deaths and quicken recovery time for patients suffering the most severe form of Covid-19, a study suggests.
US researchers reported a 91 percent survival rate in seriously ill patients given the stem cell infusion, compared to 42 per cent in a second group who did not receive the treatment.
The adult stem cells SCRI uses include umbilical cord (Mesenchymals and others), Wharton's Jelly, placenta-derived, and a patient's own bone marrow.